In Memory[]
Patient Information[]
Age: 31
Sex: Male
Diagnosed: 2/98
Location: Pass Christian, Miss
Diagnosis: DSRCT
Hospital Memorial Sloan-Kettering Cancer Center
- Oncologist: Brian H. Kushner, MD
- Surgeon: Michael P. La Quaglia, FACS, FRCS
Passed Away: 05/05
[BACK]
Treatment[]
Surgery
- Successful and nearly cancer free Dr. Michael LaQuaglia - MSKCC
Chemotherapy
- Kushners' P6 First Line - P6
- Cytoxin, Vincristine, Adriamycin
- Etoposide (VP-16) & Ifosfamide (Ifex)
- Cytoxin & Topotecan
Stem Cell Transplant
- 3 days of Thiotepa, 3 days of Carboplatin
Radiation
- Radiation at MSKCC - Twice daily for 2 weeks. Many health complications for 3 months
Clinical Trials
Experimental
- Experimental vaccine at MSKCC - (A1G4) Ten shots spread out regressively beginning with the first 3 every other week, next 3 once a month, remaining 4 every other month. Very few side effects. No evidence that it worked because cancer came back.
Complimentary Treatment
- Essiac tea, Unda herbal liquid drops, vitamins & minerals, Ensure Plus, Theramag pad, acupuncture.
Time Line[]
| Date | Test | Treatment | Chemicals | Result | |
|---|---|---|---|---|---|
| 2/19/98 | 0 | 0 | 0 | Diagnosed | |
| 12/98 | 0 | Chemotherapy 1 - Kushners P6 Protocol | Cytoxin, Vincristine, Adriamycin | 0 | |
| 3/98 | 0 | Chemotherapy 2 | Etoposide (VP-16) & Ifosfamide (Ifex) | 0 | |
| 4/98 | 0 | Chemotherapy 3 | Cytoxin Topotecan Dr. Kushner - MSKCC (N.Y.) | 0 | |
| 5/98 | 0 | Chemotheapy 4 | Cytoxin Topotecan Dr. Kushner - MSKCC (N.Y.) | 0 | |
| 5/98 | 0 | Debulking surgery | 0 | Successful and nearly cancer free. Dr. Michael LaQuaglia MSKCC | |
| 6/98 | 0 | Chemotherapy 5 | Cytoxin, Adriamycin & Vincristine | 0 | |
| 7/98 | 0 | Chemotherapy 6 | Cytoxin, Adriamycin & Vincristine | 0 | |
| 8/98 | 0 | Chemotherapy 7 | Cytoxin, Adriamycin & Vincristine | 0 | |
| 9/98 | 0 | Stem Cell Transplant | High dosage: 3 days of Thiotepa, 3 days of Carboplatin | 0 | |
| 10/98 | 0 | 0 | 0 | 0 | |
| 11/98 | 0 | 0 | 0 | 0 | |
| 12/98 | 0 | Radiation | 0 | Twice daily for 2 weeks. Many health complications for 3 months | |
| 1/99 | 0 | 0 | 0 | 0 | |
| 2/99 | 0 | 0 | 0 | 0 | |
| 3/99 | 0 | 0 | 0 | 0 | |
| 4/99 | 0 | 0 | 0 | 0 | |
| 5/99 | 0 | 0 | 0 | 0 | |
| 6/99 | 0 | 0 | 0 | 0 | |
| 7/99 | 0 | 0 | 0 | 0 | |
| 8/99 | 0 | 0 | 0 | 0 | |
| 9/99 | 0 | Experimental vaccine at MSKCC - (A1G4) | 0 | Ten shots spread out regressively beginning with the first 3 every other week, next 3 once a month, remaining 4 every other month. No evidence that it worked because cancer came back. | |
| 10/99 | 0 | Experimental vaccine at MSKCC - (A1G4) | 0 | No evidence that it worked because cancer came back. | |
| 11/99 | 0 | Experimental vaccine at MSKCC - (A1G4) | 0 | 0 | |
| 12/99 | 0 | Experimental vaccine at MSKCC - (A1G4) | 0 | 0 | |
| 1/00 | 0 | Experimental vaccine at MSKCC - (A1G4) | 0 | 0 | |
| 2/00 | 0 | Experimental vaccine at MSKCC - (A1G4) | 0 | 0 | |
| 3/00 | 0 | Experimental vaccine at MSKCC - (A1G4) | 0 | 0 | |
| 4/00 | 0 | Experimental vaccine at MSKCC - (A1G4) | 0 | 0 | |
| 5/00 | 0 | Experimental vaccine at MSKCC - (A1G4) | 0 | 0 | |
| 6/00 | 0 | Experimental vaccine at MSKCC - (A1G4) | 0 | 0 | |
| 7/00 | 0 | Experimental vaccine at MSKCC - (A1G4) | 0 | 0 | |
| 8/00 | 0 | Experimental vaccine at MSKCC - (A1G4) | 0 | 0 | |
| 9/00 | 0 | Experimental vaccine at MSKCC - (A1G4) | 0 | 0 | |
| 10/00 | 0 | Experimental vaccine at MSKCC - (A1G4) | No evidence that it worked because cancer came back. | ||
| 11/00 | 0 | Chemotherapy | High dosage: CPT-11 Camptosar (Irinotecan) | 0 | |
| 12/00 | 0 | 0 | 0 | 0 | |
| 1/01 | 0 | 0 | 0 | 0 | |
| 2/01 | 0 | 0 | 0 | 0 | |
| 3/01 | 0 | 0 | 0 | 0 | |
| 4/01 | 0 | 0 | 0 | 0 | |
| 5/01 | 0 | 0 | 0 | 0 | |
| 6/01 | 0 | 0 | 0 | 0 | |
| 7/01 | 0 | 0 | 0 | 0 | |
| 8/01 | 0 | 0 | 0 | 0 | |
| 9/01 | 0 | 0 | 0 | 0 | |
| 10/01 | 0 | 0 | 0 | 0 | |
| 11/01 | 0 | 0 | 0 | 0 | |
| 12/01 | 0 | New protocol of hormone blocker treatment (Nupron) | 0 | Damage health. Rapid muscle deterioration, hot flashes & night sweats. | |
| 1/02 | 0 | 0 | 0 | 0 | |
| 2/02 | 0 | 0 | 0 | 0 | |
| 3/02 | 0 | 0 | 0 | 0 | |
| 4/02 | 0 | 0 | 0 | 0 | |
| 5/02 | 0 | 0 | 0 | 0 | |
| 6/02 | 0 | 0 | 0 | 0 | |
| 7/02 | 0 | 0 | 0 | 0 | |
| 8/02 | 0 | 0 | 0 | 0 | |
| 9/02 | 0 | 0 | 0 | 0 | |
| 10/02 | 0 | Alternative treatment at Burzynski Clinic in Houston, Texas. | Antineoplasm & Herceptin treatment | Made him sick | |
| 11/02 | 0 | Alternative treatment at Burzynski Clinic in Houston, Texas. | Antineoplasm & Herceptin treatment | Stopped treatment | |
| 12/02 | CT | Chemotherapy | Doxil(Doxorubicin) & Ifosfamide | Significant shrinkage after two rounds | |
| 1/03 | 0 | Chemotherapy | Doxil(Doxorubicin) & Ifosfamide | 0 | 0 |
| 2/03 | 0 | Chemotherapy | Doxil(Doxorubicin) & Ifosfamide | 0 | |
| 3/03 | 0 | Chemotherapy | Doxil(Doxorubicin) & Ifosfamide | 0 | |
| 4/03 | 0 | Chemotherapy | Doxil(Doxorubicin) & Ifosfamide | Increased dosage - Tumors began to grow | |
| 5/03 | 0 | Chemotherapy | Thalidomide - Oral dose | 0 | |
| 6/03 | 0 | Chemotherapy | Thalidomide - Oral dose | 0 | |
| 7/03 | 0 | Chemotherapy. Intensity Modulated Radiation Therapy (IMRT). 35 treatments. Tumors shrunk about 40% | Thalidomide - Oral dose | 0 | |
| 8/03 | 0 | Chemotherapy. Intensity Modulated Radiation Therapy | Thalidomide - Oral dose | 0 | |
| 9/03 | 0 | Chemotherapy.Intensity Modulated Radiation Therapy | Thalidomide - Oral dose | Tumors shrunk about 40% from IMRT | |
| 10/03 | 0 | Chemotherapy | Thalidomide - Oral dose | 0 | |
| 11/03 | 0 | Chemotherapy | Thalidomide - Oral dose | 0 | |
| 12/03 | 0 | Chemotherapy | Thalidomide - Oral dose | 0 | |
| 1/04 | 0 | Chemotherapy | Thalidomide - Oral dose. Daily Gleevac | 0 | |
| 2/04 | 0 | Chemotherapy. Daily Gleevac | Thalidomide - Oral dose | Tumors grew. Bad side effects | |
| 3/04 | 0 | Chemotherapy | Daily Gleevac | 0 | |
| 4/04 | 0 | Chemotherapy | Daily Gleevac | 0 | |
| 5/04 | 0 | Chemotherapy | Daily Gleevac | 0 | |
| 5/12/04 | 0 | Surgery | 0 | Exploratory surgery revealed 2cm area of DSRCT in and on skull | |
| 5/23/06 | 0 | Radiation | 0 | Received 20 IMRT radiation treatments to affected skull area | |
| 6/04 | 0 | Chemotherapy | Daily Gleevac | Gleevac discontinue because tumors still gowing | |
| 6/11/04 | 0 | Chemotherapy 1 | 4 rounds of CPT-11 Camptosar (Irinotecan)- once a week | Cancer found around left temple | |
| 7/04 | 0 | Chemotherapy 2 | CPT-11 Camptosar (Irinotecan) | 0 | |
| 8/04 | 0 | Chemotherapy 3 | CPT-11 Camptosar (Irinotecan) | 0 | |
| 9/04 | 0 | Chemotherapy 4 | CPT-11 Camptosar (Irinotecan) | 0 | |
| 9/30/04 | Chemotherapy | Decitabine | Phase II Cinical Trial at M.D. Anderson (Houston, Tx.) | ||
| 10/04 | CT Scan | 0 | 0 | Lump on cheek developed. Ended Decitabine trial | |
| 11/04 | 0 | 0 | 0 | 0 | |
| 12/13/04 | 0 | Clinical Trial | 0 | ET-743 (Ecteinascidia turbinata) - Sea Squirts (New Orleans) | |
| 1/05 | 0 | 0 | 0 | 0 | |
| 2/05 | 0 | 0 | 0 | 0 | |
| 3/05 | 0 | 0 | 0 | 0 | |
| 4/05 | 0 | 0 | 0 | 0 | |
| 5/05 | 0 | 0 | 0 | Passed Away |
7 1/2y
[BACK]